A group of union and health care advocates are warning that allowing the Yale New Haven Health System to affiliate with Lawrence and Memorial Health will exponentially increase its market share and put upward pressure on prices. Vincent Petrini, senior vice president for public affairs at Yale-New Haven Hospital, took issue with the market concentration figures in the report, as well as speculation on price increases, the relative size of the Yale New Haven Hospital System and the methodology of groups analyzing quality care. … The proposal for L+M is one of five major hospital affiliations pending for action by OCHA. The report points out that if the five requests are approved, more than 80 percent of patients in the state will get their care at hospitals “owned by large, powerful multi-hospital systems.”
Critics seek hard look at Yale–L+M deal, hospital market power
group of unions and advocacy organizations are calling for state regulators to take a hard look at the growth in power and market concentration of large health systems in Connecticut – and what that means for patients – when they review the Yale New Haven Health System’s proposed acquisition of New London’s Lawrence + Memorial Hospital. “The acquisition of Lawrence + Memorial health by the Yale-New Haven Health Services Corporation is a pivotal opportunity for stemming the growth of monopoly in Connecticut’s health care market and limiting the ill effects of consolidation,” they said in a report issued Tuesday by seven groups: the unions AFSCME Council 4, AFT Connecticut, UNITE HERE! Connecticut, and New England Health Care Employees Union, District 1199, SEIU; the Connecticut Citizen Action Group; the Connecticut Health Policy Project; and United Action Connecticut.